Elevated Serum Amyloid A2 and A4 in Patients With Guillain–Barré Syndrome
Increased levels of SAA2 and SAA4 may only represent the acute inflammatory status and so cannot be utilized as biomarkers of the disease severity or demyelinating injury in patients with GBS.
Authors
- Baojun Qiao (ORCID: https://orcid.org/0009-0007-3172-1395)
- Yan Song (ORCID: https://orcid.org/0000-0001-8491-8836)
- Q L Zhang
- Jin Won Song (ORCID: https://orcid.org/0009-0000-1323-5579)
- Fangzhen Shan (ORCID: https://orcid.org/0000-0002-3703-1893)
- Yuzhong Wang (ORCID: https://orcid.org/0000-0002-3145-9362)
- Xiaoying Yao (ORCID: https://orcid.org/0000-0001-6087-7996)
Institutions
- Affiliated Hospital of Jining Medical University (CN)
Publication Details
- Journal
- Journal of Clinical Neurology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.3988/jcn.2024.0469
- Citations
- 3
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 4.17
Funders
- Jining Medical University